Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2011-01-24

FDA Approved: OXALIPLATIN — Original Application (Sandoz Inc)

View source ↗

Summary

FDA approved Sandoz's generic oxaliplatin through an Original Application (ANDA). The approval supports the use of oxaliplatin for colorectal cancer treatment.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • OXALIPLATIN (Oxaliplatin)

Snippet

ORIG AP for OXALIPLATIN (OXALIPLATIN)